AstraZeneca’s Evusheld monoclonal antibodies combo for pre-exposure prophylaxis receives EUA
by Press Release from Outbreak News Today on (#5SW5R)
NewsDesk @infectiousdiseasenews On Wednesday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca's Evusheld for the pre-exposure prophylaxis of COVID-19 in certain adults and pediatric individuals- 12 years of age and older weighing at least 40 kilograms [about 88 pounds]. Evusheld is tixagevimab co-packaged with cilgavimab and administered together. The product [...]
The post AstraZeneca's Evusheld monoclonal antibodies combo for pre-exposure prophylaxis receives EUA appeared first on Outbreak News Today.